Childhood hepatitis C virus infection: An Australian national surveillance study of incident cases over five years

Journal of Paediatrics and Child Health

Volumn 51, Issue 11, 2015, Pages 1115-1120

  Raynes Greenow, Camille ^a   Polis, Suzanne ^b,c   Elliott, Elizabeth ^a,d   Hardikar, Winita ^e,f,g   Kesson, Alison ^a,h,i   Kaldor, John ^b   Jones, Cheryl A ^a,h,i  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ST GEORGE HOSPITAL   (Australia)

^e Australian Paediatric Surveillance Unit   (Australia)

^f CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

Author keywords

Australia; child; epidemiology; hepatitis C; vertical transmission

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BREAST FEEDING; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; HEALTH SERVICE; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOASSAY; INCIDENCE; JAUNDICE; LIVER FAILURE; LIVER FUNCTION TEST; MALE; MATERNAL WELFARE; MIXED INFECTION; PRENATAL CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUESTIONNAIRE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; VERTICAL TRANSMISSION; HEPACIVIRUS; INFANT; PREVENTION AND CONTROL; PROSPECTIVE STUDY; TRANSMISSION;

ADOLESCENT; AGE DISTRIBUTION; AUSTRALIA; CHILD; CHILD, PRESCHOOL; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INCIDENCE; INFANT; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84946492162     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.12904     Document Type: Article

References (41)

1. World Health Organization. Hepatitis C, 2014. Available from: http://www.who.int/mediacentre/factsheets/fs164/en/ [accessed April 2015].
2. Parliament of New South Wales Legislative Council Standing Committee on Social Issues. Hepatitis C: the neglected epidemic. Report number 16. November 1998.
3. The Kirby Institute UNSW Australia. HIV, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report. 2012.
4. Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ,. Vertical transmission of hepatitis C: systematic review and meta-analysis. Clin. Infect. Dis. 2014; 59: 765-773.
5. Gibbs DM, Goodall RL, Dunn DT, et al. Mother to child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet 2000; 356: 904-907.
6. Resti M, Azzari C, Galli L, et al. Maternal drug use is a preeminent risk factor for mother-to-child hepatitis C virus transmission: results from a multicenter study of 1372 mother-infant pairs. J. Infect. Dis. 2002; 185: 567-572.
7. Spencer JD, Latt N, Beeby PJ, et al. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J. Viral Hepat. 1997; 4: 395-409.
8. Cottrell E, Chou R, Wasson N,. Reducing risk for mother to child transmission of hepatitis C virus: a systematic review for the US preventative services task force. Ann. Intern. Med. 2013; 158: 109-113.
9. Garazzino S, Calitri C, Versace A, et al. Natural history of vertically acquired HCV infection and associated autoimmune phenomena. Eur. J. Pediatr. 2014; 173: 1025-1031.
10. Resti M, Jara P, Hierro L, et al. Clinical features and progression of perinatally acquired hepatitis C virus infection. J. Med. Virol. 2003; 70: 373-377.
11. Bortolotti F, Iorio R, Resti M, et al. An epidemiological survey of hepatitis C virus infection in Italian children in the decade 1990-1999. J. Pediatr. Gastroenterol. Nutr. 2001; 32: 562-566.
12. Yeung LT, To T, King SM, Roberts EA,. Spontaneous clearance of childhood hepatitis C virus infection. J. Viral Hepat. 2007; 14: 797-805.
13. Rerksuppaphol S, Hardikar W, Dore GJ,. Long term outcome of vertically acquired and post-transfusion hepatitis C infection in children. J. Gastroenterol. Hepatol. 2004; 19: 1357-1362.
14. Bortolotti F, Verucchi G, Cammà C,. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 2008; 134: 1900-1907.
15. Jonas MM,. Children with hepatitis C. Hepatology 2002; 36 (5 Suppl. 1): S173-178.
16. Rumbo C, Fawaz RL, Emre SH, et al. Hepatitis C in children: a quaternary referral center perspective. J. Pediatr. Gastroenterol. Nutr. 2006; 43: 209-216.
17. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N. Engl. J. Med. 1999; 341: 866-870.
18. Tovo PA, Pembrey LJ, Newell ML,. Persistence rate and progression of vertically acquired hepatitis C infection. European Paediatric Hepatitis C Virus Infection. J. Infect. Dis. 2000; 181: 419-424.
19. Hardikar W,. Natural history and treatment of hepatitis C infection in children. J. Gastroenterol. Hepatol. 2004; 19: S379-381.
20. Serranti D, Indolfi G, Resti M,. New treatments for chronic hepatitis C: an overview for paediatricians. World J. Gastroenterol. 2014; 20: 15965-15974.
21. Liu AJW, An EI, Murray HG, Tetstall E, Leroi MJ, Nanan RKH,. Screening for hepatitis C virus infection in methadone-maintained mothers and their infants. Med. J. Aust. 2009; 191: 535-538.
22. Kanaan T, Liu A, Leroi M, Nanan R,. A multicentre survey of hepatitis C awareness in a high-risk population. J. Paediatr. Child Health 2013; 49: 648-653.
23. Zurynski Y, Srikanthan S, Elliott EJ, eds. 20 Years of Research into Rare Diseases. Sydney: Australian Paediatric Surveillance Unit, 2013. ISBN: 978-0-9923042-0-1.
24. Australian Bureau of Statistics 2001. Standard Population for use in Age Standardisation, data cube: cat. no. 31010DO003-201212, 2001. Available from: http://www.abs.gov.au/ausstats/absattheratr.nsf/Lookup/3101.0 [accessed December 2013].
25. Laws P, Abeywardana S, Walker J, Sullivan E,. Australia's Mothers and Babies 2005. Perinatal Statistics Series;No.20 AIHW. 2007.
26. National Notifiable Diseases Surveillance System (NNDSS) Annual Report Writing Group. Australia's Notifiable Disease Status, 2012: Annual report of the National Notifiable Diseases Surveillance System., Hepatitis C, 2012. pp. 33-39. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/ohp-communic-1 [accessed April 2015].
27. Cox L,. Protecting confidentiality in small population health and environmental statistics. Stat. Med. 1996; 15: 1895-1905.
28. Nightingale S, Stormon MO, Day AS, Webber MT, Ward KA, O'Loughlin EV,. Chronic Hepatitis B and C infection in children in New South Wales. Med. J. Aust. 2009; 190: 670-673.
29. Alter MJ,. Epidemiology of hepatitis C virus infection. World J. Gastroenterol. 2007; 13: 2436-2441.
30. Hardikar W, Elliot EJ, Jones CA,. The silent infection: should we be testing for perinatal hepatitis C and if so how? Med. J. Aust. 2006; 184: 54-55.
31. Spencer JD, Tibbits D, Tippet C, Mead C, Kaldor JM, Dore GJ,. Review of antenatal testing policies and practice for HIV and hepatitis C infection. Aust. N. Z. J. Public Health 2003; 27: 614-619.
32. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Management of Hepatitis C in Pregnancy (C-Obs-51). July, 2013. Available from: www.ranzcog.edu.au/college-statements-guidelines [accessed June 2014].
33. National HCV Testing Policy Expert Reference Committee 2011. National HCV Testing Policy Commonwealth of Australia, 2012. Available from: http://www.som.uq.edu.au/media/341396/hepc-testing-policy-2012.pdf [accessed April 2015].
34. Yeung LT, King SM, Roberts EA,. Mother-to-infant transmission of hepatitis C virus. Hepatology 2001; 34: 223-229.
35. Li Z, Zeki R, Hilder L, Sullivan EA,. Australia's mothers and babies 2011.no. 28.Cat. no. PER 59. Perinatal statistics series. National Perinatal Epidemiology and Statistics Unit. Sydney: AIHW, 2013.
36. Razavi H, ElKhoury AC, Elbasha E, et al. Chronic hepatitis C virus (HCV) disease burden and cost in the United States. Hepatology 2013; 57: 2164-2170.
37. Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382: 1564-1574.
38. Claret-Teruel G, Noguera-Julian A, Esteva C, et al. Impact of human immunodeficiency virus coinfection on the progression of mother-to-child transmitted Hepatitis C virus infection. Pediatr. Infect. Dis. J. 2011; 30: 801-804.
39. Palasanthiran P, Starr M, Jones C, Giles ME, eds. Hepatis C virus. In: Management of Perinatal Infections. Sydney: Australasian Society for Infectious Diseases, 2014; 21-27. Available from: www.asid.net.au [accessed April 2015].
40. Giles ML, Pedrana A, Jones C, Garland S, Hellard M, Lewin SR,. Antenatal screening practice for infectious diseases by general practitioners in Australia. Aust. N. Z. J. Obstet. Gynaecol. 2009; 49: 39-44.
41. Conte D, Fraquelli M, Prati D, Colucci A, Minola E,. Prevalence and clinical course of chronic Hepatitis C Virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 2000; 31: 751-755.